KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash & Equivalents (2019 - 2025)

Hims & Hers Health (HIMS) has disclosed Cash & Equivalents for 7 consecutive years, with $228.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 3.63% to $228.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $228.6 million through Dec 2025, up 3.63% year-over-year, with the annual reading at $228.6 million for FY2025, 3.63% up from the prior year.
  • Cash & Equivalents hit $228.6 million in Q4 2025 for Hims & Hers Health, down from $345.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q2 2025 to a low of $46.8 million in Q4 2022.
  • Historically, Cash & Equivalents has averaged $170.1 million across 5 years, with a median of $92.4 million in 2021.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 7633.13% in 2021 and later plummeted 48.64% in 2022.
  • Year by year, Cash & Equivalents stood at $71.8 million in 2021, then crashed by 34.84% to $46.8 million in 2022, then soared by 106.67% to $96.7 million in 2023, then soared by 128.2% to $220.6 million in 2024, then grew by 3.63% to $228.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for HIMS at $228.6 million in Q4 2025, $345.8 million in Q3 2025, and $1.1 billion in Q2 2025.